Objectives: Multidrug efflux pumps are thought to be involved in mediating multidrug resistance in Pseudomonas aeruginosa. Here we aim to characterize hitherto uncharacterized multidrug efflux pumps from P. aeruginosa.
Introduction
Several mechanisms are known by which microorganisms escape the toxicity of antimicrobial agents. Extrusion of toxic compounds from microbial cells is one of these mechanisms. Multidrug efflux pumps extrude many structurally unrelated compounds, and are thus involved in multidrug resistance. So far, five major groups of multidrug efflux pump are known: the MFS (major facilitator super) family, the SMR (small multidrug resistance) family, the RND (resistance nodulation cell division) family, the MATE (multidrug and toxic compounds extrusion) family and the ABC (ATP binding cassette) family.
Pseudomonas aeruginosa shows significant degrees of intrinsic and acquired resistance to a wide variety of antimicrobial agents, including most β-lactams, fluoroquinolones, tetracycline, chloramphenicol, erythromycin and so on. This is a serious clinical problem because P. aeruginosa is a major opportunistic pathogen and a leading cause of nosocomial infections. At least six RND family drug efflux pumps are known to exist in cells of P. aeruginosa, MexAB-OprM, 1 MexCD-OprJ, 2 MexEF-OprN, 3 MexXY-OprM, 4 MexJK-OprM 5 and MexHI-OpmD 6 (H. Sekiya and T. Tsuchiya, unpublished results). Among these Mex pumps, expression of MexAB-OprM is constitutive and is further enhanced in the presence of antimicrobial agents in the growth medium. Both MexCD-OprJ and MexXYOprM are expressed only under conditions where inducing drugs are present. MexEF-OprN and MexJK are silent in wild-type P. aeruginosa. Whole genome sequence information of P. aeruginosa is now available, 7 and suggests the presence of about 10 RND family multidrug efflux pumps in this microorganism. Previously, we reported the functional cloning of multidrug resistance genes of P. aeruginosa using a drug-hypersensitive Escherichia coli mutant as a host, and obtained many candidate plasmids conferring multidrug resistance. 4 We were able to clone mexAB, mexCD and mexXY, but not others. 4 It is very likely that mutation in hitherto uncharacterized pumps would lead to other multidrug resistances. It is valuable to isolate multidrug-resistant mutants from a P. aeruginosa strain that lacks major multidrug efflux operons. 8 It is expected that silent gene(s) for multidrug efflux pumps is(are) functional in such mutants. Here we report the isolation of such a mutant, the functional cloning of genes for a new member of an RND-type multidrug efflux pump (MexVW) from the mutant and properties of the pump.
Materials and methods
Strains and growth P. aeruginosa PAO1, YM44 (∆mexAB, ∆mexCD-oprJ, ∆mexEF-oprN, ∆mexXY), YM442, a drug-resistant derivative of YM44, and YM64 (∆mexAB-oprM, ∆mexCD-oprJ, ∆mexEF-oprN, ∆mexXY) 8 were used in this study. YM44 was constructed by Flp-FRT recombination technology as described for YM64. 8, 9 Bacterial cells were grown in L medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl, pH 7) at 37°C under aerobic conditions.
Isolation of drug-resistant mutants
Cells of P. aeruginosa YM44 were grown in the L medium and were spread onto L agar plates containing four-fold higher concentrations (0.25 mg/L) than the MICs for norfloxacin. We obtained many colonies that appeared on the plates after incubation at 37°C for 20 h. After single colony isolation, we checked the drug resistance patterns of the mutants. One of the mutants, which showed resistance to several antimicrobial agents, was designated YM442, and used for further analysis.
Gene manipulation
Chromosomal DNA was prepared from cells of YM442. The DNA was partially digested with a restriction endonuclease Sau3AI, separated by sucrose density gradient centrifugation, and 4-10 kilobase pair (kbp) fragments were collected. A shuttle vector pUCP20T for P. aeruginosa and E. coli was used as a cloning vector. The chromosomal DNA fragments were ligated to the BamHI site of pUCP20T. The hybrid plasmids were introduced into cells of YM44 by electroporation. Transformants appeared on LB agar plates containing carbenicillin 50 mg/L and norfloxacin 0.5 mg/L. After single colony isolation, plasmid DNA was prepared from the cells, and re-introduced into cells of YM44. Drug resistance of the re-transformant was confirmed, and the plasmid harboured by the cells was designated pER2. The size of the DNA insert in pER2 was about 14 kbp. We sub-cloned a DNA region responsible for drug resistance from pER2, and obtained plasmid pTAJ2. The size of the DNA insert in pTAJ2 was about 5.1 kbp.
The nucleotide sequence was determined by the dideoxy chain termination method 10 with an automated DNA sequencer (ALF Express, Pharmacia Biotech.).
RT-PCR
Cells of P. aeruginosa (PAO1, YM44 and YM442) were harvested at the exponential phase of growth (3 mL culture). Total cellular RNA was isolated from the cells using the Qiagen RNeasy Mini Kit (Qiagen Inc., USA), treated with RNase-free DNase (Promega, USA) (1 U of enzyme/ µg RNA for 2 h at 37°C) and re-purified using the same kit. A 1 µg sample of DNase-treated RNA was used as template for RT-PCR with the Qiagen OneStep RT-PCR Kit (Qiagen) according to the manufacturer's protocol. Primer pairs specific for and internal to both mexV and the rpsL genes (encoding a constitutively expressed ribosomal protein that was used as a control) were used for RT-PCR. Primers used for mexV were: CGTCAGCAGATCGCCCTTTTCAGC (forward) and CGCTTTTC-GAGATGGCCTTGCTGC (reverse); and for rpsL: GCAACTAT-CAACCAGCTGGTG (forward) and GCTGTGCTCTTGCAGGTTGTG (reverse). A 6 µL sample of each reaction product was analysed by agarose X (3% w/v) gel electrophoresis for presence of the expected RT-PCR products (for mexV, 331 bp; for rpsL, 220 bp).
Drug susceptibility
The MICs of various drugs were determined by the broth microdilution method with Mueller-Hinton broth (Difco) as reported previously. 8 MICs were read after 24 h at 37°C.
Ethidium bromide efflux
Cells were grown in LB medium at 37°C and harvested at the middle exponential phase of growth. Ethidium bromide efflux was measured as reported previously. 4 
Results and discussion

Isolation of drug-resistant mutant
A mutant P. aeruginosa YM44 lacking mexAB, mexCD-oprJ, mexEF-oprN and mexXY was constructed. This strain, which possesses the oprM gene, is useful for isolation of mutants showing elevated activity of the RND-type pump, which can utilize OprM as an outer membrane component of the tripartite pump. The mutant we isolated, YM442, showed elevated resistance to norfloxacin, ofloxacin, chloramphenicol, cefpirome, tetracycline, ethidium bromide and acriflavine (Table 1) . No detectable changes in the resistance levels to other β-lactams and aminoglycosides were observed compared with the parental YM44 cells. Thus, it seems that one of the hitherto uncharacterized multidrug efflux pumps became functional in the YM442 strain.
Cloning of genes responsible for multidrug resistance
We tried to clone genes responsible for the multidrug resistance mentioned above from the chromosomal DNA of the mutant YM442. After cloning and sub-cloning using YM44 as a host, we obtained a hybrid plasmid pTAJ2. Cells of YM44/pTAJ2 showed elevated resistance to norfloxacin, ofloxacin, chloramphenicol, cefpirome, tetracycline, ethidium bromide and acriflavine, but not to gentamicin (Table 1) . Thus, the drug resistance patterns in YM442 and YM44/ pTAJ2 are the same. These results support the idea that the cloned gene(s) is(are) responsible for the elevated drug resistances observed with YM442. The level of drug resistance in YM44/pTAJ2 was higher than that of YM442 to some extent. This may be because of a gene dosage effect since the cloning vector pUCP20T is a multi-copy plasmid.
We determined the nucleotide sequence of several portions of plasmid pTAJ2. We have shown that pTAJ2 carries a DNA region encompassing the open reading frames (ORFs) from PA4374 to a portion of PA4376 (Figure 1) , which have been reported in the whole genome sequence of P. aeruginosa. 7 Complete ORFs included in pTAJ2 are PA4374 and PA4375. It has been suggested that these two ORFs code for a membrane fusion protein and an RND-type drug efflux protein. 7 We designated the ORFs PA4374 and PA4375 as mexV and mexW, respectively, because deduced primary structures of these proteins are similar to those of other Mex proteins. The MexV deduced amino acid sequence showed the highest identity and similarity to MexH, 33% and 48%, respectively, and the MexW to MexI, 46% and 64%, respectively. The mexV (PA4374) gene is preceded by a promoter-like sequence. The lactose promoter of E. coli exists in the vector, but in the opposite direction in the downstream region of the part of PA4376 (Figure 1) . Thus, it is very likely that the promoter-like sequence in the pTAJ2 functions as a promoter. A terminator-like sequence is present downstream from the mexW gene. 7 We could not find an ORF near the MexVW genes that might encode a regulatory protein.
The RND-type multidrug efflux pumps consist of a membrane embedded efflux protein, a membrane fusion protein and an outer membrane channel protein. No gene for an outer membrane protein exists in the downstream region of the mexW gene (PA4375). 7 It is likely that PA4376 codes for nicotinate phosphoribosyltransferase judging from sequence similarity. It thus seemed possible that MexVW utilizes OprM as an outer membrane component. We tested this possibility by comparing the MIC values of several antimicrobial agents between YM44/pTAJ2 (possessing OprM) and YM64/pTAJ2 (not possessing OprM). Much higher MIC values were observed with YM44/pTAJ2 than with YM64/pTAJ2 (Table 1) . Thus, it is probable that OprM can function as an outer membrane component of the MexVW system. However, YM64/pTAJ2 showed several fold higher MICs than YM64. This indicates that outer membrane component(s) other than OprM can also function as a member of the tripartite MexVW system. We observed no increase in the MIC of chloramphenicol with YM64/pTAJ2, although we observed an increase in the MIC with YM44/pTAJ2 ( Table 1 ). This suggests that the (MexVW)-(OprM) pump can extrude chloramphenicol as a substrate but (MexVW)-(other outer membrane protein) pump cannot. It is interesting that the outer membrane component can affect the substrate specificity of the pump.
Drug efflux
We confirmed that MexVW is a drug efflux pump by measuring ethidium bromide efflux. Cells of YM44 showed a higher level of intracellular ethidium bromide, suggesting no or very low efflux of ethidium bromide from cells (Figure 2 ). On the other hand, the intracellular ethidium bromide level in YM442 and YM44/pTAJ2 was lower than that in YM44, suggesting efflux of ethidium bromide. The (Figure 2) . Thus, the energydependent efflux of ethidium bromide is high in these two types of cells. These results support the idea that genes on plasmid pTAJ2, namely mexV and mexW, code for a drug efflux pump.
Over-expression of the mexVW in YM442
It seemed that the mexVW operon was silent or expression was weak in wild-type P. aeruginosa and in YM44, whereas the operon was over-expressed in the mutant YM442. We confirmed by the RT-PCR method that expression of the mexV gene was very weak in wild-type PAO1 and parental YM44, and the gene was over-expressed in the mutant YM442 (roughly 4.4-fold over-expression) (Figure 3 ).
In conclusion, MexVW functions as a multidrug efflux pump using OprM or other outer membrane protein(s) as a component of the tripartite pump in the mutant YM442. Over-expression of the mexVW operon was observed with the mutant YM442 compared with wild-type PAO1 and parental YM44.
